P.090 Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
R.A. De Man, D. Mutimer, R. Gish, T. Chang, J. Zhu, A. Cross, H. Brett-SmithVolume:
36
Year:
2006
Language:
english
DOI:
10.1016/s1386-6532(06)80273-8
File:
PDF, 145 KB
english, 2006